AstraZeneca booster effective against severe COVID: UK study Ruchika Sharma7 May 2022 10:00 AM ISTThe research supports the use of the AstraZeneca booster for protection against severe disease with COVID-19 in settings that have not yet offered...
Recombinant plant-based Covid-19 vaccine promising for infection control: NEJM Medical Dialogues Editorial Team6 May 2022 10:06 AM ISTCanada: In a new study conducted by Karen J. Hager and team, it was shown that the Coronavirus-like particles (CoVLP) + Adjuvant System 03 (AS03)...
CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine Susmita Roy5 May 2022 7:10 PM ISTNew Delhi: Rejecting the vaccine major Serum Inst. of India's proposal for emergency use authorization of rBCG vaccine for prevention of Tuberculosis...
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group Ruchika Sharma5 May 2022 12:34 PM ISTThe study is likely to be conducted at six sites, including AIIMS Delhi and Patna.
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 11:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
SC finds no haste in granting EUA to covishield, covaxin MD Bureau3 May 2022 1:08 PM ISTThe bench said: "The material provided by the Union of India, comprising minutes of the meetings of the SEC, do not warrant the conclusion that...
Antibiotics use in children below 2 years tied to reduced vaccine response: Study Medha Baranwal3 May 2022 10:00 AM ISTNew York: Antibiotic use in children aged 6 to 24 months is associated with reduced vaccine-induced antibody levels to several vaccines, states a...
USFDA VRBPA committee to review Novavax COVID vaccine Ruchika Sharma2 May 2022 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2.
COVID-19: WHO backed vaccine resolution wins 24 percent support at Moderna Ruchika Sharma1 May 2022 9:30 AM ISTThe message for management from the result is "there are more important things to think about than just returns to investors," Hodgson said.
SII Covovax inclusion in vaccination drive for 12-17 age group recommended by NTAGI panel Ruchika Sharma30 April 2022 12:26 PM ISTNew Delhi: The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute's Covid jab Covovax in the national...
Govt to soon decrease gap between 2nd dose of Covid vaccine and booster dose to 6 months Medical Dialogues Bureau29 April 2022 4:00 PM ISTA recommendation on lessening the gap is expected to be made by the National Technical Advisory Group on Immunisation (NTAGI) which is set to hold a...
Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6 Ruchika Sharma29 April 2022 11:59 AM ISTModerna is also currently studying booster doses for all pediatric cohorts.
